{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-014345","form_type":"8-K","ticker":"RDGL","cik":"0001449349","company_name":"VIVOS INC","filed_at":"2025-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.014672+00:00","generated_at":"2026-05-17T05:57:54.311642+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Vivos appoints Brad Allan Weeks as President and David J. Swanberg as COO","bullets":["Brad Allan Weeks appointed President effective Sept 1, 2025, with base salary $192,000/yr plus monthly stock grants.","David J. Swanberg appointed COO via consulting agreement at $12,000/month plus stock grants.","Weeks previously served as Business Development Manager; Swanberg has 35+ years in radiochemical processing and was co-founder of IsoRay.","President term ends Dec 31, 2027; COO term ends Dec 31, 2028; both agreements include confidentiality and non-compete clauses."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-014345","json":"https://secwatch.observer/filing/0001493152-25-014345.json","markdown":"https://secwatch.observer/filing/0001493152-25-014345.md","text":"https://secwatch.observer/filing/0001493152-25-014345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1449349/000149315225014345/0001493152-25-014345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1449349/000149315225014345/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:57:54.311642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}